Literature DB >> 6285190

Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum.

P Reyes, P K Rathod, D J Sanchez, J E Mrema, K H Rieckmann, H G Heidrich.   

Abstract

Plasmodium falciparum trophozoites were isolated by mechanical rupture of infected human erythrocytes followed by a series of differential centrifugation steps. After lysis with sonication, the 100 000 x g supernatant of parasites and uninfected host cells was used to determine the specific activities of a number of enzymes involved in purine and pyrimidine metabolism. P. falciparum possessed the purine salvage enzymes: adenosine deaminase, purine nucleoside phosphorylase, hypoxanthine-guanine phosphoribosyltransferase (PRTase), xanthine PRTase, adenine PRTase, adenosine kinase. The last two enzymes, however, were present at much lower activity levels. Hypoxanthine was converted (presumably via IMP) into adenine and guanine nucleotides only in the presence both of supernatant and membrane fractions of P. falciparum. Two enzymes involved in the de novo synthesis of pyrimidines, orotic acid PRTase, and orotidine 5'-phosphate decarboxylase, were present in parasite extracts as were the enzymes for pyrimidine nucleotide phosphorylation: UMP-CMP kinase, dTMP kinase, nucleoside diphosphate kinase. Xanthine oxidase, CTP synthetase, cytidine deaminase and several kinases for the salvage of pyrimidine nucleosides were not detected in the parasites. Both phosphoribosyl pyrophosphate synthetase and uracil PRTase were present but at low activity levels. Human erythrocytes displayed similar but not identical enzyme patterns. Enzyme specific activities, however, were generally much lower than those of the corresponding parasite enzymes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285190     DOI: 10.1016/0166-6851(82)90035-4

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  66 in total

1.  Pyrophosphate interactions at the transition states of Plasmodium falciparum and human orotate phosphoribosyltransferases.

Authors:  Yong Zhang; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2010-06-30       Impact factor: 15.419

2.  Acyclic immucillin phosphonates: second-generation inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.

Authors:  Keith Z Hazleton; Meng-Chiao Ho; Maria B Cassera; Keith Clinch; Douglas R Crump; Irving Rosario; Emilio F Merino; Steve C Almo; Peter C Tyler; Vern L Schramm
Journal:  Chem Biol       Date:  2012-06-22

Review 3.  Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.

Authors:  Margaret A Phillips; Pradipsinh K Rathod
Journal:  Infect Disord Drug Targets       Date:  2010-06

Review 4.  A surprising role for uric acid: the inflammatory malaria response.

Authors:  Julio Gallego-Delgado; Maureen Ty; Jamie M Orengo; Diana van de Hoef; Ana Rodriguez
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

Review 5.  Purine salvage pathways in the intraerythrocytic malaria parasite Plasmodium falciparum.

Authors:  Megan J Downie; Kiaran Kirk; Choukri Ben Mamoun
Journal:  Eukaryot Cell       Date:  2008-06-20

6.  Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites.

Authors:  Dennis C Madrid; Li-Min Ting; Karena L Waller; Vern L Schramm; Kami Kim
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

Review 7.  Antimalarial drug discovery - approaches and progress towards new medicines.

Authors:  Erika L Flannery; Arnab K Chatterjee; Elizabeth A Winzeler
Journal:  Nat Rev Microbiol       Date:  2013-11-11       Impact factor: 60.633

8.  Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.

Authors:  Ramesh Gujjar; Alka Marwaha; Farah El Mazouni; John White; Karen L White; Sharon Creason; David M Shackleford; Jeffrey Baldwin; William N Charman; Frederick S Buckner; Susan Charman; Pradipsinh K Rathod; Margaret A Phillips
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

9.  Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase.

Authors:  P K Rathod; S Reshmi
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

10.  Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria.

Authors:  Tonia Woodberry; Alberto Pinzon-Charry; Kim A Piera; Yawalak Panpisutchai; Christian R Engwerda; Denise L Doolan; Ervi Salwati; Enny Kenangalem; Emiliana Tjitra; Ric N Price; Michael F Good; Nicholas M Anstey
Journal:  Malar J       Date:  2009-06-07       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.